Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

PD-1 and its ligands in tolerance and immunity.

Keir ME, Butte MJ, Freeman GJ, Sharpe AH.

Annu Rev Immunol. 2008;26:677-704. doi: 10.1146/annurev.immunol.26.021607.090331. Review.

PMID:
18173375
[PubMed - indexed for MEDLINE]
2.

The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.

Paterson AM, Brown KE, Keir ME, Vanguri VK, Riella LV, Chandraker A, Sayegh MH, Blazar BR, Freeman GJ, Sharpe AH.

J Immunol. 2011 Aug 1;187(3):1097-105. doi: 10.4049/jimmunol.1003496. Epub 2011 Jun 22.

PMID:
21697456
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The B7 family revisited.

Greenwald RJ, Freeman GJ, Sharpe AH.

Annu Rev Immunol. 2005;23:515-48. Review.

PMID:
15771580
[PubMed - indexed for MEDLINE]
4.

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.

Carreno BM, Collins M.

Annu Rev Immunol. 2002;20:29-53. Epub 2001 Oct 4. Review.

PMID:
11861596
[PubMed - indexed for MEDLINE]
5.

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ.

Nat Immunol. 2007 Mar;8(3):239-45. Review.

PMID:
17304234
[PubMed - indexed for MEDLINE]
6.

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.

Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ.

Immunity. 2007 Jul;27(1):111-22. Epub 2007 Jul 12.

PMID:
17629517
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The PD-1/PD-L1 pathway in human pathology.

Saresella M, Rainone V, Al-Daghri NM, Clerici M, Trabattoni D.

Curr Mol Med. 2012 Mar;12(3):259-67. Review.

PMID:
22300137
[PubMed - indexed for MEDLINE]
8.

Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.

Martin-Orozco N, Wang YH, Yagita H, Dong C.

J Immunol. 2006 Dec 15;177(12):8291-5.

PMID:
17142723
[PubMed - indexed for MEDLINE]
Free Article
9.

The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.

Yang J, Riella LV, Chock S, Liu T, Zhao X, Yuan X, Paterson AM, Watanabe T, Vanguri V, Yagita H, Azuma M, Blazar BR, Freeman GJ, Rodig SJ, Sharpe AH, Chandraker A, Sayegh MH.

J Immunol. 2011 Aug 1;187(3):1113-9. doi: 10.4049/jimmunol.1100056. Epub 2011 Jun 22.

PMID:
21697455
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.

Gotsman I, Grabie N, Dacosta R, Sukhova G, Sharpe A, Lichtman AH.

J Clin Invest. 2007 Oct;117(10):2974-82.

PMID:
17853943
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Role of PD-1 in regulating T-cell immunity.

Jin HT, Ahmed R, Okazaki T.

Curr Top Microbiol Immunol. 2011;350:17-37. doi: 10.1007/82_2010_116. Review.

PMID:
21061197
[PubMed - indexed for MEDLINE]
12.

PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.

Peña-Cruz V, McDonough SM, Diaz-Griffero F, Crum CP, Carrasco RD, Freeman GJ.

J Invest Dermatol. 2010 Sep;130(9):2222-30. doi: 10.1038/jid.2010.127. Epub 2010 May 6.

PMID:
20445553
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

PD-1 and its ligands in T-cell immunity.

Keir ME, Francisco LM, Sharpe AH.

Curr Opin Immunol. 2007 Jun;19(3):309-14. Epub 2007 Apr 12. Review.

PMID:
17433872
[PubMed - indexed for MEDLINE]
14.

Role of PD-L1 and PD-L2 in allergic diseases and asthma.

Singh AK, Stock P, Akbari O.

Allergy. 2011 Feb;66(2):155-62. doi: 10.1111/j.1398-9995.2010.02458.x. Epub 2010 Aug 17. Review.

PMID:
20722638
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.

Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, Greenfield EA, Freeman GJ.

J Immunol. 2003 Feb 1;170(3):1257-66.

PMID:
12538684
[PubMed - indexed for MEDLINE]
Free Article
16.

The PD-1 pathway in tolerance and autoimmunity.

Francisco LM, Sage PT, Sharpe AH.

Immunol Rev. 2010 Jul;236:219-42. doi: 10.1111/j.1600-065X.2010.00923.x. Review.

PMID:
20636820
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.

Goldberg MV, Maris CH, Hipkiss EL, Flies AS, Zhen L, Tuder RM, Grosso JF, Harris TJ, Getnet D, Whartenby KA, Brockstedt DG, Dubensky TW Jr, Chen L, Pardoll DM, Drake CG.

Blood. 2007 Jul 1;110(1):186-92. Epub 2007 Mar 28.

PMID:
17392506
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The role of the PD-1 pathway in autoimmunity and peripheral tolerance.

Fife BT, Pauken KE.

Ann N Y Acad Sci. 2011 Jan;1217:45-59. doi: 10.1111/j.1749-6632.2010.05919.x. Review.

PMID:
21276005
[PubMed - indexed for MEDLINE]
19.

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T.

J Exp Med. 2000 Oct 2;192(7):1027-34.

PMID:
11015443
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.

Fife BT, Bluestone JA.

Immunol Rev. 2008 Aug;224:166-82. doi: 10.1111/j.1600-065X.2008.00662.x. Review.

PMID:
18759926
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk